Key Points
- Insider buying: Francis Van Parys purchased 96 Oxford Nanopore Technologies shares at GBX 157 each, worth £150.72. This follows two earlier purchases in July and August.
- Financial performance remains weak: The company reported quarterly EPS of negative GBX 4.90, with a negative net margin of 54.66% and negative return on equity of 35.45%.
- Analysts remain broadly positive: Five analysts rate the stock Buy and one rates it Hold, producing a “Moderate Buy” consensus and an average target price of GBX 198.60 versus an opening price of GBX 155.98.
Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Francis Van Parys purchased 96 shares of the stock in a transaction that occurred on Monday, September 14th. The stock was acquired at an average cost of GBX 157 per share, with a total value of £150.72.
Francis Van Parys also recently made the following trade(s):
- On Wednesday, August 12th, Francis Van Parys purchased 114 shares of Oxford Nanopore Technologies stock. The stock was bought at an average price of GBX 131 per share, with a total value of £149.34.
- On Tuesday, July 14th, Francis Van Parys acquired 124 shares of Oxford Nanopore Technologies stock. The shares were bought at an average cost of GBX 121 per share, for a total transaction of £150.04.
Oxford Nanopore Technologies Trading Down 0.0%
Shares of ONT stock opened at GBX 155.98 on Tuesday. Oxford Nanopore Technologies plc has a 1 year low of GBX 95.61 and a 1 year high of GBX 191.40. The company has a debt-to-equity ratio of 9.86, a current ratio of 3.52 and a quick ratio of 6.01. The stock's 50 day simple moving average is GBX 134.97 and its two-hundred day simple moving average is GBX 125.83. The company has a market cap of £1.52 billion, a PE ratio of -12.48 and a beta of 0.96.
Oxford Nanopore Technologies (LON:ONT - Get Free Report) last posted its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative net margin of 54.66% and a negative return on equity of 35.45%.
Analysts Set New Price Targets
A number of research analysts have recently commented on ONT shares. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 195 price target on shares of Oxford Nanopore Technologies in a report on Thursday, August 20th. Berenberg Bank cut their target price on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating on the stock in a research report on Wednesday, August 19th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Citigroup downgraded shares of Oxford Nanopore Technologies to a "buy" rating in a research note on Monday, July 20th. Finally, Peel Hunt reissued a "hold" rating and set a GBX 153 price objective on shares of Oxford Nanopore Technologies in a report on Monday, July 13th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Oxford Nanopore Technologies has a consensus rating of "Moderate Buy" and a consensus target price of GBX 198.60.
View Our Latest Stock Report on Oxford Nanopore Technologies
About Oxford Nanopore Technologies
(
Get Free Report)
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
